J&J Expands Project That Aims to Predict, Prevent Diseases
Johnson & Johnson has ramped up its ambitious project to learn how to predict who will develop particular diseases and find therapies to prevent or stop the disease early, when it’s most treatable.
Since the health care giant announced its groundbreaking project in February 2015, it’s expanded to include two dozen research programs with partners – in government, universities, patient advocacy groups and other drug and diagnostic test companies. Their expertise and resources should speed discoveries and allow Johnson & Johnson to spread its funding across more ventures.
- Health Care